Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Agree. Caught more here 9.7 ...
IS THAT ALL THEY GOT??
I don’t believe any company trades at an eval where they profit their market cap in two years. 3.80.... your target 106 mm cap. Codx make 35-40 mm profit this year and 65-70mm profit In 2021... what company Should trade at these levels??? Codx in your eyes that would then profit their market cap by end of 2021..... Codx 12 times earnings 2020 17.08$ 15x = 21.30$ , Codx 12 times earnings 2021 = 29.89. 15x 37.36
Vaccine administration induced only low levels of IL-4 production, suggesting little risk of vaccine- dependent disease enhancement.
Of particular note, neutralizing antibodies in the lungs were observed at a very high percentage of the total antibody response
Key takeaways. Price action wasnt what all would have liked. These results do however warrant more credibility and advancement of VAXART tablet...
You are missing the points here... CODX did not fail to meet expecations and in many cases surpassed those.... take the following excerpt from your article for example....
"CoDiagnostics, Inc.Which belongs to the Zacks Medical Services industry, posted revenues of $24.04 million for the quarter ended June 2020, missing the Zacks Consensus Estimate by 10.96%. This compares to year-ago revenues of $0.06 million."
They missed estimates due to the simple fact that they were just ramping up with brand new products in a brand new market.. Numbers were not even somewhat predictable... With that being said.... 400X revenue increase. 400,000% increases in REVS. 60k to 24.04 million. In that QUARTER.
CODX has been called the gold standard of testing and still represents a 100% accuracy rating. Their partner isnt going anywhere anytime soon either! Clinical reference LABS:
"We are one of the largest privately held clinical testing laboratories in the U.S. With dedicated facilities in North America and Europe, and through our global laboratory partners, we perform hundreds of thousands of tests every day for clients large and small. Our staff of more than 600 associates works around-the-clock to process and report results seven days a week for many of the largest retail, transportation, pharmaceutical, healthcare and financial service organizations in the world."
CODX cant sustain 400,000% growth but the necessity isn't going away and huge relationships are being formed. CODX gains will continue!
Major set back in another Injectable vaccine puts Astra Zenca trials on HOLD!!! VXRT should start seeing green..
Here you go... and a week after I warned shares would be dumped... you can’t make this stuff up, just wouldn’t want you to be blindsided as the CEO PADS POCKETS
Clearly it’s a disease... Kgkg couldn’t have announced bigger and better news and where is the price??? Goodbye... total waste of time here
Next up is Disastrous financials everyone will make excuses on.
Can you not see from the previous half a dozen 8+ million share sell offs where the price is heading??
You may find a Green Day or two to make a buck but looks like new lows are coming like I said a month ago
Bye? You must be talking about a failed exit strategy. Things couldn’t be more clear here.... how many authorized shares now and how many outstanding? How many 1 year ago and two years ago? Kgkg signs massive distribution deal with company doing under 100k in revenue. Things are looking up!! Share counts will increase and value will continue to diminish.
It looks like dilution.... kgkg sinking
Umm.... tell me something trading with more value please... 3x revs on 50%+ profit margin with growth rates Far exceeding 100%+++
To date over 50 million. Profit lies between 20-25 million right now And almost 1$ per share. Something isn’t quite right is correct.... 20+++
CODX REMAINS A BUY HERE AND THE SHORTIES KNOW IT. More great news coming this week.
EXACTLY
Once the formal PR this will RIP. Look at the reaction at 2:30 once it was found and read.... CODX ADD ON!
The unique, proprietary structure of CoPrimers molecules creates reactions that are far more specific than competing PCR technologies, to better identify the presence of and distinguish between viruses, pathogens, cancer, or other attributes in agricultural or industrial applications. The prestigious Journal of Molecular Diagnostics deemed CoPrimers a TECHNICAL ADVANCE as they are 2.5 MILLION times more effective in reducing amplification errors
ADDDED TODAY AND WILL ADD MORE TOMORROW AS WELL!
Have you viewed this?
Yes! With it being so close to the START of Phase 1. VXRT does have involvement with OWS. The bombshell will be if the response comes out prior, likes the Preclinical data and the FED FUNDS phase 1 to begin immediately.
The World needs VXRT pill so even if it doesn't happen. Longterm winner still is VXRT in my opinion
Sept 9 or 10 they will begin phase 1. should see anouncement at that time.
An IND application may go into effect 30 days after FDA receives the application, unless FDA notifies the sponsor (Vaxart) that the investigations described in the application are subject to a Clinical Hold; or on earlier notification by FDA that the clinical investigations in the IND may begin.
Expecting big things here in the next week or two.... VXRT
It took all of two hours from VXRT to go from 4.51 to 6.94.
Yes, They support the decision to have the loan halted. CEO stated they support the loan being halted during the investigation. That article is misleading and KODK has no choice. They used the defense production act. Its not really up to KODK at this point, but the investigation is ongoing and as criminial as it is, they will get in the business and still receive funding for it. The article is junk.
Volume oh sooooo tiny
It’s go time 5.53 pick direction
Thanks for the input. I’m long vxrt!
What are risks at 5-6 40-50%% loss and 400%++ gain??
She’s gunna catch fire again
Waiting for news here... 29k shares ready for the surge... not likely to get anymore... but if it goes under 5 i have to be a buyer again.... 11 red in a row is draining and can understand vacating VAXART... not me... not now... news coming within two weeks... .LOOK OUT
GREAT NEWS?? I BOUGHT .0255 THIS MORNING AND SOLD .032.... its run like a Pump and dump so thast how it will be treated
WILL SHARE COUNT INCREASE AFTER THE PUMP NEWS?
Yes, They are behind the rest in terms of an outdated injectable, temperature intolerable, logistical nightmare vaccine! VXRT is however leading the pack in formulating a safe effective easy to distribute, room temp stable and PPE free administration tablet VACCINE!
WOW WHAT AN UPGRADE!!!
Where is the bid heading?!?
Just a question.... hasn't KGKG said multiple times they ditched smaller distros to sign larger more favorable agreements??? This BEV distro has 3 employees and 80k in revenue last year.... hmmm what a whopper
No doubt VAXART gets funds. A pill is necessary without question. VAXART may not lead the race but they will win it!
“Additional large-scale federal funding would likely go to a vaccine that could be delivered in one dose or orally rather than via injection.“
From the article you posted near the end of it.... (excerpt above)
Makes sense to me!
NO STRANGER TO GOVERNMENT FUNDING in the past! After all government funding was used in their most recent flu studies that provided higher reduction of actual cases and less side effects than the injectable competitor.
https://investors.vaxart.com/news-releases/news-release-details/results-influenza-challenge-study-published-lancet-infectious
FEDS WILL B ADDRESSING GROWING CONCERNS OVER REFRIGERATION ISSUES. FEDS WILL ADDRESS THE PPE AND CONSUMABLES TAKEN TO ADMINISTER THOSE.
FEDS, PHARMACIES And PHYSICIANS WILL TURN TO NO OTHER THAN VXRT.
-
Cant make this stuff up!
VXRT now conecting with its 100 moving average....
Yes, it is... The other two are entering trials soon... hmmm.. VXRT!!! Next week will be big as it inches closer! More than confident these will be seen as Cheap shares very soon!
Yup... Like the prospects for sure. Like the upcoming merger and believe it will add extreme value to the company in the long haul!
BOUGHT MORE today @ 6!
4x from here
VXRT turns the corner finishes GREEN!
THE LINK I PROVIDED IS IN REFERENCE to the professional CONCERNS about OTHER vaccine candidates. (Vaxart will not have those issues) Health professionals are concerned about the ultra low TEMPERATURES these other vaccine candidates must be stored at! BUYING more VXRT HERE WOOHOO!